EP 0934525 A1 19990811 - DOUBLE LABEL IMMUNOASSAY
Title (en)
DOUBLE LABEL IMMUNOASSAY
Title (de)
DOPPELMARKIERUNGSIMMUNTESTVERFAHREN
Title (fr)
DOSAGE IMMUNOLOGIQUE AVEC DOUBLE MARQUAGE
Publication
Application
Priority
- GB 9702552 W 19970922
- GB 9621256 A 19961011
Abstract (en)
[origin: WO9816833A1] A solid phase assay comprising: (a) providing a solid support on which is immobilised a first component of a binding interaction between the first component and a second component, the first component having a first label which is non-radioactive; (b) contacting the said solid support either (i) with a putative inhibitor of the binding interaction and the second component of the binding interaction, the second component having a second label which is non-radioactive and which is distinguishable from the first label, under conditions under which the binding interaction, in the absence of inhibitor would be expected to occur, or (ii) with a specimen to be assayed for a predetermined analyte, which analyte is the second component of the binding interaction, under conditions under which the binding interaction would be expected to occur if the analyte is present in the specimen; and (c) determining whether, or to what extent, the binding interaction has occurred.
IPC 1-7
IPC 8 full level
G01N 33/543 (2006.01); G01N 33/58 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP)
G01N 33/543 (2013.01); G01N 33/582 (2013.01); G01N 33/6863 (2013.01)
Citation (search report)
See references of WO 9816833A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9816833 A1 19980423; AU 4311497 A 19980511; EP 0934525 A1 19990811; GB 9621256 D0 19961127; ZA 978504 B 19980401
DOCDB simple family (application)
GB 9702552 W 19970922; AU 4311497 A 19970922; EP 97941088 A 19970922; GB 9621256 A 19961011; ZA 978504 A 19970922